Skip to main content

Table 1 Baseline patient characteristics

From: Predicting per-lesion local recurrence in locally advanced non-small cell lung cancer following definitive radiation therapy using pre- and mid-treatment metabolic tumor volume

ParameterCohort (n = 111)
Median age68 (42–90) years
Male77 (69.4%)
ECOG PS
 013 (11.7%)
 170 (63.1%)
 226 (23.4%)
 32 (1.8%)
Stage
 IIIA60 (54.1%)
 IIIB51 (45.9%)
Histology
 Adenocarcinoma52 (46.8%)
 Squamous Cell Carcinoma44 (39.6%)
 Large Cell3 (2.7%)
 Adenosquamous2 (1.8%)
 NOS10 (9.0%)
Median RT dose66 (60–74) Gy
 60–66 Gy84 (75.7%)
  > 66–74 Gy27 (24.3%)
Concurrent chemotherapy106 (95.5%)
Median follow up, months38.7 (0.1–109.2)
  1. Abbreviations: ECOG PS performance score, NOS not otherwise specified
  2. * Continuous variables are shown with range and categorical variables with percentages in parenthesis